Search

everythinglearnresearchcommunity

for

Search:↓

Deuruxolitinib effectively promotes hair regrowth in adults with alopecia areata.

Sorafenib may cause hand-foot and stump syndrome, requiring early detection and management.

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

Kir6.1 mutations in Cantú syndrome increase channel sensitivity and hyperpolarization, while SUR2B mutations do not.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

Dutasteride and finasteride affect different cell types differently.

Ritlecitinib is cost-effective for severe alopecia areata in Japan.

Minoxidil effectively lowers blood pressure and initially increases plasma renin activity without raising aldosterone levels.

Saw palmetto extract is effective and safe for treating lower urinary tract symptoms, working as well as certain medications, and works even better in severe cases.

SIG-1451 could be a promising new treatment for atopic dermatitis.

Severe alopecia areata may increase the risk of heart-related diseases.

CTP-543 is generally safe for treating alopecia areata.

General surgeons in India need to manage peripheral arterial disease due to a shortage of vascular surgeons.

Baricitinib treatment can help regrow scalp hair and eyebrows or eyelashes in people with severe alopecia areata.

Dutasteride and finasteride cause kidney damage, with dutasteride being more harmful.

Oral Apremilast effectively treats alopecia areata in most patients.

Ritlecitinib significantly regrows scalp hair in people with alopecia areata.

Minoxidil boosts plasma renin activity, influenced by control plasma renin activity and changes in sympathetic tone.

Rutin may protect against stomach damage caused by sodium valproate.

Upadacitinib effectively treated severe hair loss in a child.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

Adalimumab significantly improved symptoms and quality of life in two patients with Hidradenitis Suppurativa.

Baricitinib is effective and safe for treating localized vitiligo, alone or with topical tacrolimus.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

5 alpha reductase inhibitors can cause sexual, cognitive, and muscle side effects, and may slightly increase aggressive cancer risk.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Managing multiple autoimmune diseases in one patient is very challenging.

These medications for BPH have known risks and may have new side effects.